Secondary peritonitis

  • abscess
  • bowel perforation
  • ruptured appendix

- Switch to oral agents when tolerating oral intake and clinical improvement.

 

Usual Pathogens

Polymicrobial:

Enterobacterales

Enterococcus spp

Anaerobes

Streptococcus spp

Yeast

Community-acquired, low risk

Therapy Dose Duration
Ceftriaxone 100mg/kg IV q24h Duration of therapy dependent on clinical picture (see Peritonitis)
+    
Metronidazole 30mg/kg/d IV div q12h  

Alternative

Therapy Dose Duration
Amoxicillin-clavulanate

≥ 3 months old (4-40kg): 

5:1 ratio:  75mg-15mg/kg/d IV div q8h

Duration of therapy dependent on clinical picture (see Peritonitis)

Penicillin and ceftriaxone allergy

Therapy Dose Duration
Clindamycin 40mg/kg/d IV div q8h Duration of therapy dependent on clinical picture (see Peritonitis)
+    
Gentamicin 5-7mg/kg IV q24h  

Community-acquired, high risk:

  • ICU/critically ill

  • diffuse peritonitis

  • delayed or inadequate source control

or

Healthcare-associated

Therapy Dose Duration
Piperacillin-tazobactam 240-300mg piperacillin/kg/d IV div q6-8h Duration of therapy dependent on clinical picture (see Peritonitis)

If at risk for yeast infection, add:

   
Micafungin  2-4mg/kg IV daily  
If healthcare-associated and postoperative infection, add:  
Vancomycin 60mg/kg/d IV div q6h  

Penicillin allergy/Multiple previous antibiotics/known ceftriaxone-resistant Gram negative organism

Therapy Dose Duration
Meropenem 60mg/kg/d IV div q6-8h Duration of therapy dependent on clnical picture (see Peritonitis)

If at risk for yeast infection, add:

 
Micafungin  2-4mg/kg IV daily  
If healthcare-associated and postoperative infection, add:  
Vancomycin 60mg/kg/d IV div q6h